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During hemodialysis, fluid is removed from or infused into
patients after careful clinical assessment of their hydration states.
Unfortunately, these assessments are often imprecise, resulting in
either fluid overload or intravascular volume depletion. Since
hypovolemia plays an important role in symptomatic hypotension,
which complicates up to 25% of dialysis treatments [1], there has
been increased interest in blood volume (BV) monitoring in
recent years.
Previous authors have suggested monitoring change in BV
during dialysis by examining alterations in optical density [2—5],
optical reflection [6, 71, mass density [8], viscosity [9], protein
concentration [10] or electrical conductivity [11—14]. However,
none of these described methods has measured absolute BV,
which is at least as important a determinant of dialysis-related
hypotension as the relative change in BV [15, 16]. The best
method currently available is measurement of red cell and plasma
volumes by dilution of radioactively-labeled blood elements. The
_____
time-consuming nature of this method and the exposure of the
patient to radiation makes it unsuitable for routine clinical use,
especially if a number of studies are required.
To our knowledge, there has only been one previous report of
an attempt to non-invasively measure absolute blood volume in
hemodialysis patients, based on plasma density [17], but this was
improperly validated against anthropometric calculations derived
from a normal, healthy population.
We have developed a novel, non-invasive method of measuring
absolute BV by photometric means, which we have previously
validated in Vitro [18]. The purpose of this study was to validate
the technique in ViVO, comparing the results obtained in ten
hemodialysis patients with those obtained using radioisotope
dilution techniques.
Methods
Physical principle
When light in the near infrared range (810 nm) is passed
through a column of blood within transparent dialysis blood lines,
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it is predominantly absorbed by hemoglobin (Hb), independently
of its degree of oxygen saturation [18—201. Provided column width
is constant, the natural log of the attenuated optical signal, [Ln
(P)], is inversely proportional to hemoglobin concentration ([Hb])
over the ranges of [Hb] usually encountered in hemodialysis
patients (50 glliter to 120 glliter) [4]. By collecting blood samples
to calibrate the optical monitor's output, this received optical signal
can be converted into a continuous recording of [Hb] [4]. The
subsequent calculation of absolute BV was based on a mathematical
method described by Schallenberg, Stiller and Mann [3].
Assuming ideal mixing of blood and a constant mass of
hemoglobin within the vascular compartment, [Hb] is inversely
proportional to BV. During a period of ultrafiltration between
time 0 minutes and time t minutes, the proportional BV (BV()/
BV(O)) can be calculated as follows:
—
IIFlho1
1
BV(o) [Hb(t)]
°
As fluid is removed by ultrafiltration, oncotic pressure increases,
resulting in an unknown amount of vascular refilling from the
interstitial compartment. The rate of change of BV at time t is
therefore equal to the refilling rate, Qr, less the ultrafiltration rate,Q.
dBV(t)/dt = Qr — Qu (Eq.2)
Using subscripts 1 and 2 to denote rates of change of volumes
during a defined time period immediately before and after a
change in ultrafiltration rate, and assuming °r does not alter
appreciably during this time, the above equation may be written
for both time periods and the difference found:
[dBV(t)Idt]2 — [dBV(t)Idt]l = (Or Qu2) (Or — 0)
= Q1 — Q2 (Eq. 3)
Both sides of equation 3 can be divided by BV(0), obtaining
Qul — °u2
[d/dt BV(t)/BV(O)12 — [d/dt BV(t>/BV(O)1I = BV(0)
This may be rearranged and combined with equation I to give:
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Fig. 1. Extracorporeal circuit for measuring a
patient's BV using optical techniques.
— Q2
BV(o) =
d/dt {[l-ib(o)]I[FTb(t)I}2 d/dt {[l—Ib(o)1/[l—Ib(t)]}l
Q1 and Q2 are easily measured. The rate of change of [Hb(o)1/
[Hb(,)1 can be calculated from the slope of the line constructed
using the recorded optical data points [4]. The patient's starting
By, BV(0), can therefore be readily calculated.
Patients
Ten stable hemodialysis patients (7 males, 3 females) gave
informed consent to enter the study, which was approved by the
Royal Brisbane Hospital Ethics Committee. All had received
three to four hours of conventional hemodialysis three times a
week using cuprophane membranes for a median period of 2.7
years (range 0.16 to 20.5 years). Median age was 67.5 years (range
39 to 76 years) and median predialysis weight was 71.1 kg (range
50.3 to 85.9 kg). The primary renal diseases included chronic
glomerulonephritis (4 patients), analgesic nephropathy (3), reno-
vascular nephrosclerosis (2) and diabetic glomerulosclerosis (1).
Apparatus
The extracorporeal circuit (Fig. 1) included a polyamide 2.0 m2
hemofilter (Gambro FH88H) and the patient's usual cuprophane
hollow-fiber dialyzer connected in series. Blood was pumped at
200 ml/min from the patient's arteriovenous fistula or subclavian
catheter through these two devices by a Cobe CentrySystem 3
automatic supply unit and returned to the patient. Anticoagula-
tion was by routine systemic heparinization.
During the study period, the dialyzer was set in bypass mode
and its input and output ports clamped, so that neither dialysis nor
ultrafiltration took place. Ultrafiltrate was only removed through
the hemofilter at a rate controlled by a peristaltic pump connected
to the ultrafiltrate port. The ultrafiltrate was collected into a
measuring cylinder and its volume continuously monitored.
The optical monitor head, based on the design of Wilkinson et
al [4], consisted of a photodetector and a laser diode with a
spectral output at the isobestic point of Hb at 810 nm. It clipped
around the "arterial" blood line proximal to the hemofilter. Two
clear perspex inserts held the PVC blood tubing firmly in place to
minimize tubing diameter variations due to pulsatile blood flow.
An optical filter was included to remove ambient light effect.
Every 0.055 seconds, the optical monitor sampled the attenuated
( 4\ power of the continuously emitted light beam after it passedthrough the blood line and the information was recorded on a
connected computer. Because of potential variations in the diam-
eters and transparencies of the blood lines between studies, five
blood samples were collected from the sample port at 7.5 minute
intervals during the 30-minute ultrafiltration phase of each exper-
iment. This enabled the optical signal output to be calibrated
against [HbI, measured using a Coulter S Counter.
Linear regression analysis was used to determine the relation-
ship between [HbJ and Ln(P), so that [Hb] could be calculated for
each optical signal value measured during the experiment [4].
In a previous in vitro validation study [18] using stored human
blood pumped around the above dialysis circuit, commonly used
blood pump speeds (150 to 300 ml/min) and varying optical
monitor positions did not affect optical responses. Varying [Hb] in
the range of 4 to 12 g/dl did not significantly disturb the linear
relationship between [HbI and Ln(P). Accuracy was impaired by
only more extreme degrees of red cell hemolysis (sufficient to
cause discoloration of ultrafiltrate). However, because high access
recirculation could have potentially produced spuriously low BV
estimates, pilot in vivo studies were also performed in two patients
with arterial connections to a central venous access, where the
venous connection was changed between the other lumen of the
central venous access catheter and an arteriovenous fistula. No
appreciable difference was found between BV estimates in the
same patient despite an obvious and measurable difference in the
degree of access recirculation.
Study design
Each study took place immediately prior to a patient's routine
dialysis session. Patients remained supine and fasted for two hours
before and throughout the study.
Plasma and red cell volumes were then measured by standard
radioisotope dilution methods [21], using '311-labeled albumin
and 51Cr-labeled red cells, respectively. BV(o) was calculated by
the summation of these volumes. To conduct a cross-check on the
validity of this measurement, a whole blood/venous hematocrit
ratio was performed.
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End of ultrafiltration
Fig. 2. Typical tracing of received optical power
versus time in one pilot study patient before, during
and after a period of isolated ultrafiliration.
The patient was then connected to the extracorporeal circuit
after the priming volume of saline had been discarded. This was
followed by a 15-minute equilibration period in which blood was
pumped through the circuit without ultrafiltration taking place.
Approximately 900 ml of ultrafiltrate was then withdrawn at a
constant rate over 30 minutes. A further 15-minute equilibration
period without fluid removal followed. The ultrafiltrate port of the
hemofilter was then clamped and the patient received his or her
usual dialysis.
Two separate photometric determinations of BV(o) were made
using data obtained when ultrafiltration rate abruptly changed at
the start (BV(O)start) and end (BV(O)end) of the ultrafiltration
phase. At the start of ultrafiltration, Q equalled 0 mi/mm and
Q2 equaled the measured ultrafiltration rate. At the end of
ultrafiltration, Q equaled the measured ultrafiltration rate and
QU2equaled 0 mI/mm. The sampling time period, t, for calculating
each BV(o) was set at 4.58 minutes (or 5000 data points) before
and after the change in ultrafiltration rate on the basis of preliminaiy
studies. d/dt {[Hb](o)/[HbI(t)}l and d/dt {[Hb](o)/[l-Ib(t)}2 were cal-
culated from the slopes of the regression lines of [Hb] versus time
over the 4.58 minutes before and after the change ir ultrafiltration
rate. BV(o) was then calculated (Eq. 4).
BV measurements by the radioisotope and photometric meth-
ods were performed by different observers who were blinded to
each other's results. When all ten patients had been studied, the
paired results were compared using linear regression analysis.
Statistical analysis
Statistical analysis was performed using the software package,
Sigmastat version 1.01. Data were initially tested for normality
(Kolmogorov-Smirnov test), homoscedacity and sequential corre-
lation of adjacent error terms (Durbin-Watson statistic). Compar-
isons between radioisotope and photometric BVs were carried out
using the Mann-Whitney rank sum test. The relationship between
the two methods was then compared using linear regression
analysis. The 0.05 level of significance was used for all analyses.
Results
Effect of fluid removal on received optical power
A typical tracing of received optical power versus time is shown
in Figure 2. Prior to the commencement of ultrafiltration, when
equilibration was taking place, there was little overall change in
received optical power. During ultrafiltration, the received signal
intensity decreased as BV contracted. However, after the first five
minutes, the rate of decline of received optical power decreased
due to a progressive increase in vascular refilling rate. This
refilling continued for a short period of time after the completion
of ultrafiltration, leading to a small rebound increase in the signal.
The optical tracings of all patients revealed sizeable moment-
to-moment signal variations, which effectively translated into
fluctuations in [HbI of up to 3.5%. The magnitude of these signal
fluctuations was generally greater toward the end of ultrafiltration
and greater in the eight study patients with intact spleens com-
pared with two study patients who were asplenic.
Ln (P) versus [Hb]
Calibration plots of [Hb] versus Ln(P) in individual patients
were all associated with highly statistically significant (P < 0.01)
correlation coefficients in excess of 0.97 (Fig. 3).
Comparison of BV measurement by photometric and radioisotope
dilution techniques
Radioisotope BVs (BVRJ) ranged between 4.077 liter and 6.211
liter, with a median value of 4.9 19 liter. In each case, the whole
blood/venous hematocrit ratio was within the anticipated range of
0.84 to 0.95.
Photometrically-derived BVs calculated from optical signals
collected around the start of ultrafiltration (BV(O)start) ranged
between 1.817 liter and 10.05 liter (median 5.127 liter). The data
passed tests for normality (P > 0.2) and homoscedacity (P =
0.296), and the Durbin-Watson statistic was 2.456. A Mann-
Whitney rank sum test revealed no significant difference in outcomes
Start of ultrafiltration
—1200
0
I• F 'I
500 1000 1500
r F I
2000 2500 3000 3500
Time, seconds
258 Johnson et al: Optical measurement of absolute BV
8.5 9 9.5
Hemoglobin concentration [Hb], g/dI
.
0 2 4
Optically
6
measured By,
8 10
liters
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5.456 5.025—5.886
4.686 4.368—5.004
5.971 5.297—6.642
5.097 4.782—5.411
5.108 4.791—5.425
4.704 4.390—5.018
4.434 4.039—4.828
4.116 3.584—4.648
5.018 4.716—5.320
4.407 4.002—4.812
between BV()rt and BVRI (P> 0.1). Moreover, photometrically-
derived BVs correlated strongly with radioisotope BVs (r = 0.822;P = 0.004; SEE 0.403; y = 3.707 + 0.225x; Fig. 4). The 95%
confidence limits for the predicted BVs derived from the regres-
sion equation, y = 3,707 + 0.225x, were of the order of 400 ml
(Table 1).
By contrast, photometrically-derived BVs calculated from op-
tical signals collected at the end of ultrafiltration (BV(())end)
showed much greater variability (median 6.726 liter, range 3.8 to
24.32 liter). Although rank sum testing failed to detect a signifi-
cant difference in test outcomes by the two methods, optically
measured BVs were poorly correlated with radioisotope BVs (r =
0.035; P = 0.929).
Discussion
We have described a new optical method for measuring abso-
lute By, which is quick, inexpensive and non-invasive (above and
beyond the degree of invasiveness required for routine hemodi-
alysis). The method is based on the difference in rates of change
of optical density of blood during a brief time period before and
after a change of ultrafiltration rate. By assuming that vascular
refilling is constant during the brief time period, this unknown
quantity can be cancelled out of the calculations, allowing deter-
mination of absolute By. Photometric determinations of BV
obtained when ultrafiltration rate abruptly changed from 0 mI/mm
to 30 ml/min at the commencement of ultrafiltration (BV(O)start)
correlated strongly (r = 0.822, P = 0.004) with BV measurements
using the standard technique of radioisotope dilution (BVRI).
This enabled calculation of predicted BVs with 95% confidence
limits of approximately 400 ml. A poorer correlation was seen
between BVRI and photometric BV measurements obtained when
ultrafiltration was abruptly ceased (r = 0.035).
There are two principal potential sources of error when apply-
ing the technique around the start of ultrafiltration. The first is
due to the possible occurrence of significant change in vascular
refilling rate immediately after the alteration in ultrafiltration
rate, thus invalidating the assumptions used in deriving Equation
3. An appreciable increase or decrease in vascular refilling rate
during the measurement period could lead to an overestimation
or underestimation of absolute By, respectively.
The second potential error can arise from calculating the rate of
change of [HbI, (and hence, By), when there are marked
moment-to-moment fluctuations in the received optical signal.
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Fig. 3. Typical correlation plot obtained in one of
10 the study patients between [HbJ and Ln (P) during
isolated ultrafiltration (y = 111.045 — 7.957x; r =
—0.973; N = 5; P = 0.008; SEE = 0.236).
Fig. 4. Comparison of BVs derived by the new
optical method and those derived by standard
radioisotope dilution techniques in ten
hemodialysis patients (y = 3.707 + 0.225x; r =
12 0.822; P = 0.004; SEE = 0.403). 95%
confidence intervals for the regression line are
represented by dotted lines.
Table 1. Predicated BVs for 10 hernodialysis patients calculated by
applying the regression equation, y = 3.707 + 0.225x, to optically
measured BVs
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These signal fluctuations have also been reported with techniques
that measure BV change on the basis of blood viscosity [9] and
plasma protein concentration [10]. They were of similar magni-
tude and may therefore predominantly represent rapid fluid shifts
between different compartments within the vascular space. A
small proportion of the oscillations may also be accounted for by
splenic mobilization of small boluses of red cells into the circula-
tion, given that the magnitude of oscillations appeared less
marked in two asplenic patients. More studies are needed to
distinguish between these possibilities.
The potential error due to an alteration in vascular refilling rate
is minimized by the use of a small sampling period after the
ultrafiltration rate is changed. However, errors due to moment-
to-moment signal variations become more significant when short
time periods are selected, due to the collection of a smaller
number of data points for calculation of the regression line. This
especially applies to data collected at the end of ultrafiltration,
where signal variations were more marked, and this probably
accounts for the poor correlation of BV(O)efldwith BVRI.
A time period of 4.58 minutes (5000 data points) was therefore
selected after preliminary studies to attempt to minimize both
sources of error. The curtailment of these errors at the start of
ultrafiltration was supported by the failure of the Mann-Whitney
rank sum test to find any evidence that BV(O)start systematically
over- or underestimated BVRI.
Potential errors arising from intertreatment variations in opti-
cal path length and tubing transparency were circumvented by
calibrating the received optical power with [Hb] for each patient.
We also avoided errors induced by an effect of changing erythro-
cyte mean corpuscular volume (MCV) on received optical power
by removing fluid during isolated ultrafiltration, where plasma
osmolarity, and hence MCV, does not alter [22]. However, further
work is needed to assess the validity of the photometric method in
certain uncommon clinical circumstances, such as patients with
hemoglobinopathies or excessive Rouleaux formation.
For any given dialysis session, once initial absolute BV is
established photometrically, the same equipment can be used to
continuously measure absolute BV during subsequent ultrafiltra-
tion in the same dialysis session. Use of the regression equation
y = 3.707 + 0.225x enables optically measured BY to be trans-
lated into isotopically measured BY with a 95% confidence limit
of 400 ml. This represents a potential variation of 8.1% in the
median value of 4.919 liters for the radio isotopically measured
BYs. However, given that the isotope method itself can incur
error rates as high as 10% [23, 24], a significant portion of the
measured variation between the two methods will be due to errors
in the reference method itself.
Nevertheless, the size of the variation could be potentially large
enough to limit the clinical utility of the photometric method. A
future clinical study is therefore planned to monitor photometric
measurements of absolute BY continuously in individual patients
during symptomatic hypotension. It is our expectation that com-
parisons performed on an individual rather than a population
basis will further improve sensitivity and accuracy, and thereby
assist clinicians in detecting and preventing symptomatic hypoten-
sion related to hypovolemia. The concept of "dry weight" could
hopefully therefore be supplemented with "dry BY." This is
superior to the use of target [Hb], as has been proposed by Steuer,
Harris and Connis [2] and de Yries et al [6, 7], because of the
tendency of Hb mass to change with time (such as with bleeding,
erythropoietin therapy, etc.).
Additional potential future applications of this method in the
hemodialysis setting may include guiding the prescription of
certain treatments (such as fluid removal on dialysis and exchange
volumes for plasma exchange) and monitoring the BY effects of
various treatments (such as erythropoietin therapy). It may fur-
ther prove to be a useful research tool to investigate the physiol-
ogy of BY responses to ultrafiltration. In a previous in vitro
validation study [18], we have demonstrated that the technique
can be adapted to measure the rate of fluid refilling from the
interstitial compartment to the vascular compartment during
ultrafiltration. Inadequate vascular refilling is suspected to be a
major cause for dialysis-related hypotension [17], but has not been
readily measurable previously.
In summary, the optical technique described in this paper is
quick, simple, inexpensive and noninvasive. Photometric BYs
measured at the commencement of a period of isolated ultrafil-
tration correlated strongly with BYs derived by the standard
technique of radioisotope dilution. Taken in conjunction with
clinical assessment, the method may enable a more accurate
assessment of intravascular hydration to be performed. Future
studies are planned to assess the ability of continuous photometric
BY measurements to predict and avoid the development of
symptomatic hypotension due to hypovolemia.
Reprint requests to Dr. David Johnson, Department of Medicine, Level 3,
Wallace Freeborn Professorial Block, Royal North Shore Hospita4 St.
Leonard's, Sydney, NSW, Australia 2065.
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